Actually, the combination of digital epidemiology with selective biobanking recent analysis suggested that instead of autoantibodies, the elevated plasma levels of IL-6, IL-1β and TNF-α is in the core of the clinical symptoms of PASC COVID-19 (220). This evidence concerns the gene IL1B and COVID-19.